Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
INTRODUCTION TO AUTONOMIC NERVOUS SYSTEM Peripheral NS: nerve fibers that carry information between CNS and other parts of the body Peripheral nervous system (PNS)Afferent (sensory) Efferent (motor) nervous system From CNS to effector organs Autonomic nervous system sympathetic Somatic efferent system parasympathetic nerves To CNS from external environment and internal organs The autonomic nervous system (ANS): ANS: the involuntary branch of the peripheral efferent division not under direct conscious control- involuntary; concerned primarily with visceral functions—cardiac output, blood flow, digestion, etc—that are necessary for life Somatic division is : largely nonautonomic concerned with consciously controlled functions such as movement, respiration, and posture. ANATOMY OF THE ANS Divided into the sympathetic (thoracolumbar) division and the parasympathetic (craniosacral) division Both divisions originate in nuclei* within the central nervous system (CNS) and give rise to preganglionic efferent fibers that exit from the brain stem or spinal cord and terminate in motor ganglia. *Nucleus: demarcated mass of cell bodies in the brain The enteric nervous system (ENS) ENS: is a large and highly organized collection of neurons located in the walls of the GIT It is sometimes considered a 3rd division of the ANS Includes: the myenteric plexus (MP) and the submucous plexus (SMP) NEUROTRANSMITTER CHEMISTRY OF THE ANS Peripheral fibers that synthesize and release Ach (acetylcholine) are termed cholinergic fibers, ie, they act by releasing ACh. These include: 1. all preganglionic efferent autonomic fibers somatic (nonautonomic) motor fibers to skeletal muscle all parasympathetic postganglionic (some NO/ peptides) a few sympathetic postganglionic fibers (e.g. sweat glands and some blood vessels in the skeletal muscles) Some neurons in the CNS 2. 3. 4. 5. NEUROTRANSMITTER CHEMISTRY OF THE ANS Adrenergic neurons: Most sympathetic postganglionic terminals Adrenal medulla Some neurons in the CNS What is co-transmission? Key features of neurotransmitter function that represent potential targets of pharmacologic therapy: 1. 2. 3. 4. 5. Synthesis Storage Release Activation of receptors Termination of action of the transmitter Cholinergic Transmission The terminals of cholinergic neurons contain large numbers of vesicles that contain Ach in high concentration and other molecules (eg, peptides) (cotransmitters); Ach is synthesized in the cytoplasm from acetyl-CoA and choline through the action of choline acetyltransferase (ChAT); Acetyl-CoA is synthesized in mitochondria botulinum toxin type a <chemical> A neurotoxin produced by clostridium botulinum. When consumed in contaminated food it can cause paralysis and death. In its purified form, it has been used in the treatment of blepharospasm and strabismus. Pharmacological action: neuromuscular agents. Adrenergic Transmission The synthesis of the adrenergic transmitters is more complex than that of acetylcholine. In the adrenal medulla and certain areas of the brain, NE is further converted to epinephrine. Several important processes in the noradrenergic nerve terminal are potential sites of drug action. 1. The conversion of tyrosine to dopa, is the rate-limiting step in NE synthesis, Adrenergic Transmission How does indirect sympathomimetics (tyramine and amphetamines) act? 1. 2. They are taken up into noradrenergic nerve endings by uptake 1 → may displace NE from storage vesicles, inhibit monoamine oxidase (MAO) → ↑ NE activity in the synapse. Adrenergic Transmission 1. 2. 3. 4. Processes that terminate NE action: Metabolism by MAO and COMT simple diffusion away from the receptor site (with eventual metabolism in the plasma or liver) reuptake into the nerve terminal (uptake 1) or into perisynaptic glia or smooth muscle cells (uptake 2) Metabolism of catecholamines Brain Massage: 1. 2. 3. 4. 5. What is the mechanism of action of the following? Botulinum toxins Cocaine Tricyclic antidepressants Amphetamines Tyramine Tyramine-rich Foods Red plums, figs, raisins, avocados, green bean pods, pcikeled hearrings, druy sausages, canned meat, yogurt, soup cubes, commercial gravies, chocolate and soy sauce AUTONOMIC RECEPTORS The primary Ach receptor subtypes were named after the alkaloids originally used in their identification: muscarine and nicotine The term cholinoceptor denotes receptors (both muscarinic and nicotinic) that respond to acetylcholine The term adrenoceptor is used to describe receptors that respond to catecholamines such as NE. Autonomic receptor types with documented or probable effects on peripheral autonomic effector tissues. Typical Locations Receptor Name Result of Ligand Binding Cholinoceptors Muscarinic M1 CNS neurons, sympathetic postganglionic neurons, some presynaptic sites Formation of IP3 and DAG, increased intracellular calcium Muscarinic M2 Myocardium, smooth muscle, some presynaptic sites Opening of potassium channels, inhibition of adenylyl cyclase Muscarinic M3 Exocrine glands, vessels (smooth muscle and endothelium) Formation of IP3 and DAG, increased intracellular calcium Nicotinic NN Postganglionic neurons, some presynaptic cholinergic terminals Opening of Na+, K+ channels, depolarization Nicotinic NM Skeletal muscle neuromuscular endplates Opening of Na+, K+ channels, depolarization Adrenoceptors Alpha1 Postsynaptic effector cells, especially smooth muscle Formation of IP3 and DAG, increased intracellular calcium Alpha2 Presynaptic adrenergic nerve terminals, platelets, lipocytes, smooth muscle Inhibition of adenylyl cyclase, decreased cAMP Beta1 • Postsynaptic effector cells, especially heart, lipocytes, brain, • presynaptic adrenergic and cholinergic nerve terminals Stimulation of adenylyl cyclase, increased cAMP Beta2 Postsynaptic effector cells, especially smooth muscle and cardiac muscle Stimulation of adenylyl cyclase and increased cAMP Beta3 Postsynaptic effector cells, especially lipocytes Stimulation of adenylyl cyclase and increased cAMP Dopamine receptors D1 (DA1), D5 Brain; effector tissues, especially smooth muscle of the renal vascular bed Stimulation of adenylyl cyclase and increased cAMP D2 (DA2) Brain; effector tissues especially smooth muscle; presynaptic nerve terminals Inhibition of adenylyl cyclase; increased potassium conductance D3 Brain Inhibition of adenylyl cyclase D4 Brain, cardiovascular system Inhibition of adenylyl cyclase Dopamine selectivity is dose-dependent Dopamine Dosing 1-5 mcg/kg/min IV (low dose): May increase urine output and renal blood flow 5-15 mcg/kg/min IV (medium dose): May increase renal blood flow, cardiac output, heart rate, and cardiac contractility 20-50 mcg/kg/min IV (high dose): May increase blood pressure and stimulate vasoconstriction; may not have a beneficial effect in blood pressure; may increase risk of tachyarrhythmias May increase infusion by 1-4 mcg/kg/min at 10-30 min intervals until optimum response obtained Titrate to desired response NONADRENERGIC, NONCHOLINERGIC NEURONS Such fibers may be both motor and sensory (eg, in the gut, airways, bladder). Peptides are the most common transmitters. Other transmitters: NO, purines, serotonin, cholecystokinin, enkephalins The enteric system in the gut wall is the most extensively studied. The ENS contains nonadrenergic, noncholinergic, in addition to cholinergic and adrenergic fibers FUNCTIONAL ORGANIZATION OF AUTONOMIC ACTIVITY FUNCTIONAL ORGANIZATION OF AUTONOMIC ACTIVITY parasympathetic system is trophotropic (leading to growth) used to “rest and digest” (eg, slowing of the heart and stimulation of digestive activity) sympathetic system is ergotropic (leading to energy expenditure) that is activated for "fight or flight." (eg, cardiac stimulation, ↑ blood sugar, and cutaneous vasoconstriction) FUNCTIONAL ORGANIZATION OF AUTONOMIC ACTIVITY cooperative interactions between the parasympathetic and sympathetic systems: eg, the sensory carotid sinus baroreceptor fibers in the glossopharyngeal nerve (the ninth cranial nerve) have a major influence on sympathetic outflow from the vasomotor center Direct effects of autonomic nerve activity on some organ systems. Effect of Organ Sympathetic Activity Parasymp. Activity Action1 Action Receptor Eye Iris Radial muscle Circular muscle Ciliary muscle Contracts ... [Relaxes] α1 Heart Sinoatrial node Ectopic pacemakers Contractility Accelerates Accelerates Increases Contracts Relaxes [Contracts] Relaxes Blood vessels Skin, splanchnic vessels Skeletal muscle vessels Endothelium Receptor ... Contracts Contracts ... M3 M3 β1,β2 β1,β2 β1,β2 Decelerates ... Decreases (atria) M2 α β2 α M3 . . . . . . . . ... β . . . . . . . . Releases EDRF ... M2 . . . . . . . . M34 Effect of Organ Bronchiolar smooth muscle Gastrointestinal tract Smooth muscle Walls Sphincters Secretion Myenteric plexus Genitourinary smooth muscle Bladder wall Sphincter Uterus, pregnant Penis, seminal vesicles Sympathetic Activity Parasymp. Activity Action1 Action Receptor Receptor Relaxes β2 Contracts M3 Relaxes Contracts ... α2,5 β2 α1 Contracts Relaxes Increases Activates M3 M3 M3 M1 Relaxes Contracts Relaxes Contracts β2 α1 β2 α Contracts Relaxes ... Contracts M3 M3 Ejaculation α Erection ... ... M3 M Effect of Organ Skin Pilomotor smooth muscle Sweat glands Thermoregulatory Apocrine (stress) Metabolic functions Liver Liver Fat cells Kidney Autonomic nerve endings Sympathetic Parasympathetic NBVascular Sympathetic Activity Parasymp. Activity Action1 Action Receptor Contracts α Increases Increases M α Gluconeogenesis Glycogenolysis Lipolysis Renin release β2,α β2,α β3 β1 ... ... Decreases ACh release α Receptor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Decreases NE release ... M6 ... smooth m. in skeletal m has sympathetic cholinergic dilator fibers. The endothelium of most blood vessels releases EDRF which causes marked vasodilation, in response to muscarinic stimuli. These muscarinic receptors are not innervated and respond only to circulating muscarinic agonists. Integration of Cardiovascular Function Changes in any variable contributing to MAP → homeostatic responses to compensate for the change. Eg, NE is a powerful vasoconstrictor → ↑ peripheral vascular resistance → ↑ mean arterial pressure. In the absence of reflex control—in a patient who has had a heart transplant—the drug's effect on the heart is also stimulatory; ie, it ↑heart rate and contractile force. Integration of Cardiovascular Function In a subject with intact reflexes, the negative feedback baroreceptor response to ↑ MAP → decreased sympathetic outflow to the heart and ↑ in parasympathetic (vagus nerve) discharge at the cardiac pacemaker → the net effect of ordinary pressor doses of NE is to produce a marked ↑ in peripheral vascular resistance, a moderate ↑ in MAP, & ↓ HR (heart rate) - the exact opposite of the drug's direct action. Presynaptic Regulation α2 receptor located on noradrenergic nerve terminals. This receptor is activated by NE ↓further release of NE from these nerve endings Conversely, a presynaptic β receptor appears to facilitate the release of NE. Presynaptic receptors that respond to the transmitter substances released by the nerve ending have been called autoreceptors. Postsynaptic Regulation 1. Up- and down-regulation occur in response to ↓ or ↑ activation, respectively, of the receptors. (Eg, surgical denervation of skeletal muscle results in marked proliferation of nicotinic cholinoceptors over all parts of the fiber) Postsynaptic Regulation 2. Modulation of the primary transmitter-receptor event by events evoked by the same or other transmitters acting on different postsynaptic receptors. PHARMACOLOGIC MODIFICATION OF AUTONOMIC FUNCTION Table 6-5: Not important Drugs that block action potential propagation (local anesthetics) are very nonselective in their action, Drugs that act on the biochemical processes involved in transmitter synthesis and storage are more selective, Activation or blockade of effector cell receptors offers maximum flexibility and selectivity of effect. Individual subgroups can often be selectively activated or blocked within each major type. Example: Pharmacology of the eye The eye is a good example of an organ with multiple ANS functions Anterior chamber is the site of several tissues controlled by ANS: 1. 3 muscles: pupillary dilator and constrictor, and ciliary Secretory epithelium of the ciliary body 2. Example: pharmacology of the eye - - Parasympathetic (muscarinic): contraction of the circular muscles (miosis) Contraction of ciliary muscle: (1) accommodation (2) outflow of aqueous humour Alpha-adrenopceptors radial muscles (mydriasis) Beta-adrenoceptors ciliary epithelium facilitate secretion of aqueous humour